Vivimed Labs Ltd Locks at Lower Circuit With 1.98% Loss — Sellers Queue, No Buyers in Sight

Lower Circuit Event and Unfilled Supply

The stock, trading in the BE series, faced a 2% price band on this session, which capped the maximum daily loss at 1.98%. The closing price of Rs 5.44 was also the session low and high, indicating that the price remained locked at the circuit throughout the day. This scenario is typical of a lower circuit event where supply overwhelms demand to the extent that the exchange's circuit breaker mechanism intervenes to halt further decline. The presence of unfilled supply means sellers were queuing to exit positions but found no buyers willing to transact at lower prices — a situation that can exacerbate exit difficulties, especially in micro-cap stocks like Vivimed Labs Ltd.

Delivery and Volume Analysis

Contrary to what might be expected in a capitulation scenario, delivery volumes on 29 Sep 2026 fell sharply by 87.16% compared to the 5-day average, registering only 650 shares delivered. This decline in delivery volume suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. On a lower circuit day, rising delivery volumes typically signal holders offloading actual shares, but here the data points to a different dynamic — does this reduced delivery volume indicate a less severe capitulation or a build-up of latent selling pressure? The total traded volume was negligible at 0.00031 lakh shares, with turnover barely reaching ₹0.000016 crore, reflecting extremely thin liquidity and limited market participation.

Intraday Price Action

The stock opened and closed at Rs 5.44, the circuit price, with no intraday price movement recorded. This narrow intraday range indicates that the stock was locked at the lower circuit from the outset, with no opportunity for price discovery or recovery during the session. The absence of any higher intraday price levels suggests that demand was absent throughout the day, reinforcing the notion of persistent unfilled supply. How does this lack of intraday price flexibility affect the potential for a rebound or further declines?

Moving Averages and Trend Context

Vivimed Labs Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning confirms a sustained downtrend and suggests that the lower circuit event is an acceleration of existing weakness rather than an isolated shock. The stock’s inability to breach any of these moving averages signals a lack of technical support, which may prolong the period of selling pressure. Does the technical profile of Vivimed Labs show any nearby support, or is more downside likely?

Liquidity and Exit Risk in a Micro-Cap Context

With a market capitalisation of just ₹45.11 crore, Vivimed Labs Ltd falls squarely in the micro-cap segment. The liquidity profile is extremely thin, as evidenced by the negligible turnover and traded volume on the day of the circuit lock. The stock’s trade size based on 2% of the 5-day average traded value is effectively zero, underscoring the difficulty for any sizeable position to exit without significant price impact. This illiquidity compounds the exit risk — sellers who want to liquidate holdings face a market with no willing buyers, potentially leading to multi-day circuit locks. With unfilled sell orders at Rs 5.44 and near-zero liquidity, how deep is the exit problem for Vivimed Labs and what would need to change for normal trading to resume?

Fundamental Snapshot

Vivimed Labs Ltd operates in the Pharmaceuticals & Drugs industry, a sector that often experiences volatility linked to regulatory and market dynamics. While the company’s micro-cap status limits its trading liquidity, the fundamental backdrop remains a secondary consideration in the face of the current technical and market pressures. The stock has been on a two-day losing streak, falling 3.89% over that period, underperforming its sector by 1.62% on the latest session.

Conclusion: Severity of the Move and Liquidity Caveats

The locking of Vivimed Labs Ltd at its lower circuit price of Rs 5.44 on a 2% band day reflects a market where sellers are unable to find buyers, creating unfilled supply and a frozen price. The falling delivery volume suggests speculative short-selling rather than outright capitulation, but the micro-cap status and extremely low liquidity amplify the exit risk for holders. Trading below all moving averages confirms the technical weakness, while the absence of intraday price movement underscores the lack of demand. After a 1.98% single-day loss at lower circuit, is Vivimed Labs approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Liquidity and Exit Risk Warning: As a micro-cap stock with a market cap of ₹45.11 crore and negligible daily turnover, Vivimed Labs Ltd faces significant exit risk when locked at lower circuit. Sellers may find it difficult to exit positions without further price concessions, potentially leading to prolonged circuit locks and illiquid trading conditions.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today